Nepal vs United Arab Emirates: Share of people with HIV who receive antiretroviral therapy
Nepal
77.0%
in 2024
United Arab Emirates
77.0%
in 2024
Nepal rank
59th
United Arab Emirates rank
59th
Share of people with HIV who receive antiretroviral therapy over time
- Nepal
- United Arab Emirates
How they compare
Nepal currently reports 77.0% against 77.0% in United Arab Emirates, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was United Arab Emirates ahead.
Nepal ranks 59th and United Arab Emirates ranks 59th of 143 countries.
Across the 3 decades both report, Nepal averaged higher in 1 and United Arab Emirates in 2.
Head to head by decade
| Decade | Nepal | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.9% | 19.0% | 17.1% | United Arab Emirates |
| 2010s | 29.8% | 27.1% | 2.7% | Nepal |
| 2020s | 66.8% | 73.6% | 6.8% | United Arab Emirates |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Nepal or United Arab Emirates?
- Nepal, at 77.0% against 77.0% in United Arab Emirates as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Nepal and United Arab Emirates?
- 0.0%, with Nepal ahead.
- How many years of comparable data are there for Nepal and United Arab Emirates?
- 25 years are reported by both, from 2000 to 2024.
- How do Nepal and United Arab Emirates rank globally for share of people with hiv who receive antiretroviral therapy?
- Nepal ranks 59th and United Arab Emirates ranks 59th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.